Concepts (314)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Sarcopenia | 19 | 2018 | 422 | 2.10 | Why? |
| Frail Elderly | 23 | 2021 | 1427 | 1.67 | Why? |
| Geriatric Assessment | 17 | 2021 | 1372 | 1.21 | Why? |
| Polypharmacy | 6 | 2019 | 347 | 1.16 | Why? |
| Frailty | 10 | 2021 | 1432 | 0.80 | Why? |
| Geriatricians | 1 | 2020 | 71 | 0.80 | Why? |
| Aging | 20 | 2019 | 3581 | 0.77 | Why? |
| Health Services for the Aged | 4 | 2020 | 602 | 0.71 | Why? |
| Urinary Incontinence | 2 | 2018 | 148 | 0.70 | Why? |
| Nursing Homes | 11 | 2019 | 4155 | 0.68 | Why? |
| Accidental Falls | 4 | 2018 | 448 | 0.68 | Why? |
| Deprescriptions | 1 | 2019 | 294 | 0.67 | Why? |
| Home Care Services | 8 | 2018 | 1351 | 0.66 | Why? |
| Muscle, Skeletal | 7 | 2018 | 915 | 0.55 | Why? |
| Mitochondria | 5 | 2019 | 857 | 0.54 | Why? |
| Self-Help Devices | 1 | 2014 | 37 | 0.54 | Why? |
| Activities of Daily Living | 13 | 2019 | 1530 | 0.54 | Why? |
| Parkinson Disease | 7 | 2019 | 1414 | 0.50 | Why? |
| Longevity | 3 | 2018 | 159 | 0.48 | Why? |
| Independent Living | 7 | 2019 | 842 | 0.44 | Why? |
| Hearing Loss | 3 | 2018 | 225 | 0.38 | Why? |
| Down Syndrome | 3 | 2019 | 397 | 0.37 | Why? |
| Walking Speed | 2 | 2019 | 77 | 0.36 | Why? |
| Muscles | 2 | 2018 | 152 | 0.34 | Why? |
| Mobility Limitation | 3 | 2018 | 153 | 0.34 | Why? |
| Delirium | 1 | 2018 | 1061 | 0.34 | Why? |
| Aged, 80 and over | 55 | 2021 | 88759 | 0.32 | Why? |
| Physical Fitness | 4 | 2018 | 334 | 0.32 | Why? |
| Motor Activity | 2 | 2005 | 217 | 0.30 | Why? |
| Personal Satisfaction | 1 | 2014 | 1243 | 0.28 | Why? |
| Europe | 14 | 2019 | 12702 | 0.27 | Why? |
| Muscle Strength | 5 | 2018 | 317 | 0.27 | Why? |
| Urinary Catheterization | 1 | 2004 | 47 | 0.27 | Why? |
| Aged | 69 | 2021 | 215776 | 0.27 | Why? |
| Exercise | 8 | 2018 | 6771 | 0.26 | Why? |
| Osteoporosis | 3 | 2018 | 410 | 0.26 | Why? |
| Behavioral Symptoms | 2 | 2019 | 329 | 0.25 | Why? |
| Hair | 1 | 2005 | 175 | 0.25 | Why? |
| Giant Cell Arteritis | 1 | 2005 | 137 | 0.24 | Why? |
| Cognitive Dysfunction | 3 | 2019 | 1389 | 0.23 | Why? |
| Alzheimer Disease | 2 | 2017 | 1020 | 0.22 | Why? |
| Mitochondrial Dynamics | 2 | 2017 | 30 | 0.22 | Why? |
| Italy | 22 | 2021 | 38444 | 0.21 | Why? |
| Geriatric Nursing | 2 | 2019 | 96 | 0.21 | Why? |
| DNA, Mitochondrial | 2 | 2018 | 163 | 0.19 | Why? |
| Postural Balance | 2 | 2019 | 144 | 0.19 | Why? |
| Spinal Curvatures | 1 | 2019 | 28 | 0.19 | Why? |
| Homes for the Aged | 4 | 2018 | 1071 | 0.19 | Why? |
| Healthy Aging | 1 | 2021 | 147 | 0.19 | Why? |
| Digoxin | 2 | 2006 | 68 | 0.19 | Why? |
| Cardiovascular Physiological Phenomena | 1 | 2018 | 70 | 0.18 | Why? |
| Disruptive, Impulse Control, and Conduct Disorders | 1 | 2018 | 19 | 0.18 | Why? |
| Arthralgia | 1 | 2020 | 173 | 0.18 | Why? |
| Cognitive Reserve | 1 | 2017 | 17 | 0.18 | Why? |
| Cognitive Aging | 1 | 2017 | 12 | 0.18 | Why? |
| Anti-Ulcer Agents | 1 | 2017 | 24 | 0.18 | Why? |
| Fatigue | 2 | 2020 | 2479 | 0.18 | Why? |
| Mitochondria, Muscle | 1 | 2017 | 8 | 0.18 | Why? |
| International Classification of Diseases | 2 | 2018 | 265 | 0.18 | Why? |
| Antipsychotic Agents | 3 | 2017 | 887 | 0.18 | Why? |
| Aging, Premature | 1 | 2017 | 11 | 0.18 | Why? |
| Motor Skills | 1 | 2018 | 57 | 0.18 | Why? |
| Impulsive Behavior | 1 | 2018 | 78 | 0.18 | Why? |
| Antiparkinson Agents | 1 | 2019 | 125 | 0.18 | Why? |
| Nutritional Status | 3 | 2019 | 1403 | 0.17 | Why? |
| Hygiene | 1 | 2005 | 987 | 0.17 | Why? |
| Telomere Shortening | 1 | 2018 | 66 | 0.17 | Why? |
| Herpes Zoster Vaccine | 1 | 2019 | 112 | 0.17 | Why? |
| Clothing | 1 | 2018 | 100 | 0.17 | Why? |
| Female | 58 | 2021 | 380317 | 0.17 | Why? |
| Bone Resorption | 1 | 2017 | 61 | 0.16 | Why? |
| Posture | 1 | 2018 | 199 | 0.16 | Why? |
| Cerebral Palsy | 1 | 2018 | 156 | 0.16 | Why? |
| Cognition Disorders | 2 | 2018 | 574 | 0.16 | Why? |
| Male | 54 | 2021 | 367725 | 0.16 | Why? |
| Anemia | 2 | 2018 | 789 | 0.15 | Why? |
| Syndrome | 2 | 2019 | 1310 | 0.15 | Why? |
| Quality Indicators, Health Care | 2 | 2018 | 580 | 0.15 | Why? |
| Education, Nursing, Continuing | 1 | 1997 | 129 | 0.15 | Why? |
| Executive Function | 1 | 2017 | 173 | 0.15 | Why? |
| Mortality | 3 | 2018 | 7132 | 0.15 | Why? |
| Humans | 88 | 2021 | 930598 | 0.15 | Why? |
| Restraint, Physical | 1 | 2016 | 74 | 0.15 | Why? |
| Dopamine Agents | 1 | 2014 | 20 | 0.14 | Why? |
| Focus Groups | 1 | 2019 | 811 | 0.14 | Why? |
| Amino Acids | 1 | 2018 | 552 | 0.14 | Why? |
| Prejudice | 1 | 1997 | 245 | 0.14 | Why? |
| Bone and Bones | 1 | 2017 | 235 | 0.14 | Why? |
| Cardiotonic Agents | 1 | 1997 | 418 | 0.14 | Why? |
| Bone Density | 1 | 2017 | 335 | 0.14 | Why? |
| Levodopa | 1 | 2014 | 87 | 0.13 | Why? |
| Cholesterol | 1 | 2018 | 660 | 0.13 | Why? |
| Cognition | 4 | 2018 | 1394 | 0.13 | Why? |
| Disability Evaluation | 5 | 2018 | 671 | 0.13 | Why? |
| Psychiatric Status Rating Scales | 2 | 2017 | 1340 | 0.13 | Why? |
| Human Activities | 1 | 2015 | 293 | 0.13 | Why? |
| Inservice Training | 1 | 1997 | 477 | 0.13 | Why? |
| Comorbidity | 8 | 2019 | 34796 | 0.13 | Why? |
| Biomarkers | 6 | 2019 | 23361 | 0.13 | Why? |
| Inflammation | 5 | 2018 | 13255 | 0.12 | Why? |
| Absorptiometry, Photon | 3 | 2018 | 168 | 0.12 | Why? |
| Exosomes | 1 | 2019 | 567 | 0.12 | Why? |
| Israel | 2 | 2019 | 2751 | 0.12 | Why? |
| Selenium | 1 | 2018 | 412 | 0.12 | Why? |
| Proton Pump Inhibitors | 1 | 2017 | 377 | 0.12 | Why? |
| Cross-Sectional Studies | 17 | 2021 | 53120 | 0.12 | Why? |
| Vision Disorders | 1 | 2015 | 260 | 0.12 | Why? |
| Drug Utilization | 5 | 2018 | 619 | 0.12 | Why? |
| Extracellular Vesicles | 1 | 2019 | 607 | 0.12 | Why? |
| Pneumococcal Vaccines | 1 | 2017 | 571 | 0.11 | Why? |
| Hospitals, Teaching | 1 | 2020 | 1609 | 0.11 | Why? |
| Disease Outbreaks | 1 | 2020 | 27595 | 0.11 | Why? |
| Dyslipidemias | 1 | 2018 | 791 | 0.11 | Why? |
| Diagnostic Errors | 1 | 1997 | 865 | 0.11 | Why? |
| Disabled Persons | 2 | 2017 | 1152 | 0.11 | Why? |
| Physician's Role | 1 | 2020 | 853 | 0.11 | Why? |
| Prevalence | 9 | 2018 | 25773 | 0.11 | Why? |
| Infection Control | 1 | 2020 | 23131 | 0.11 | Why? |
| Physical Examination | 1 | 2017 | 755 | 0.11 | Why? |
| Exercise Therapy | 2 | 2017 | 976 | 0.10 | Why? |
| Renal Insufficiency | 1 | 1997 | 810 | 0.10 | Why? |
| Quality of Life | 5 | 2018 | 9820 | 0.10 | Why? |
| Pulmonary Disease, Chronic Obstructive | 2 | 2018 | 3832 | 0.10 | Why? |
| Remote Sensing Technology | 1 | 2014 | 351 | 0.10 | Why? |
| Phytotherapy | 1 | 2017 | 743 | 0.10 | Why? |
| Precision Medicine | 1 | 2020 | 1477 | 0.10 | Why? |
| Nursing Staff | 1 | 1997 | 542 | 0.10 | Why? |
| Depressive Disorder | 2 | 2017 | 1236 | 0.10 | Why? |
| Chronic Disease | 4 | 2018 | 5139 | 0.10 | Why? |
| Drug Interactions | 1 | 2017 | 1653 | 0.10 | Why? |
| Logistic Models | 7 | 2018 | 9089 | 0.10 | Why? |
| Hip Fractures | 1 | 2017 | 667 | 0.10 | Why? |
| Multimorbidity | 3 | 2021 | 703 | 0.09 | Why? |
| Medication Errors | 2 | 2010 | 107 | 0.09 | Why? |
| Long-Term Care | 2 | 2018 | 2047 | 0.09 | Why? |
| Proteins | 1 | 2017 | 921 | 0.09 | Why? |
| Cardiovascular Diseases | 4 | 2018 | 11497 | 0.09 | Why? |
| Longitudinal Studies | 3 | 2019 | 9893 | 0.09 | Why? |
| Carrier State | 1 | 2020 | 2100 | 0.09 | Why? |
| Body Mass Index | 2 | 2018 | 4306 | 0.09 | Why? |
| Multiple Myeloma | 1 | 1997 | 1064 | 0.09 | Why? |
| Fever | 1 | 2005 | 7795 | 0.09 | Why? |
| Robotics | 1 | 2014 | 528 | 0.09 | Why? |
| Medication Adherence | 1 | 2017 | 1270 | 0.09 | Why? |
| Inappropriate Prescribing | 1 | 2010 | 284 | 0.08 | Why? |
| Dyspnea | 1 | 2020 | 3847 | 0.08 | Why? |
| Cholinergic Antagonists | 1 | 2006 | 56 | 0.08 | Why? |
| Dementia | 2 | 2016 | 1861 | 0.08 | Why? |
| Anthropometry | 2 | 2017 | 233 | 0.08 | Why? |
| Hand Strength | 3 | 2018 | 202 | 0.08 | Why? |
| Emergency Service, Hospital | 2 | 2021 | 14232 | 0.07 | Why? |
| Malnutrition | 1 | 2014 | 932 | 0.07 | Why? |
| Stress Disorders, Post-Traumatic | 1 | 2021 | 2963 | 0.07 | Why? |
| Patient Readmission | 1 | 2014 | 1543 | 0.07 | Why? |
| Patient Selection | 1 | 2018 | 4560 | 0.07 | Why? |
| Age Factors | 4 | 2017 | 21039 | 0.07 | Why? |
| Atrial Fibrillation | 1 | 2018 | 2320 | 0.06 | Why? |
| Body Composition | 2 | 2018 | 414 | 0.06 | Why? |
| Risk Factors | 12 | 2021 | 71621 | 0.06 | Why? |
| Cohort Studies | 9 | 2018 | 36005 | 0.06 | Why? |
| Follow-Up Studies | 5 | 2020 | 17020 | 0.06 | Why? |
| Telemedicine | 1 | 2014 | 25032 | 0.06 | Why? |
| Proportional Hazards Models | 4 | 2017 | 6543 | 0.06 | Why? |
| Middle Aged | 19 | 2021 | 270681 | 0.06 | Why? |
| Drug Prescriptions | 1 | 2010 | 1062 | 0.06 | Why? |
| Linear Models | 2 | 2018 | 1914 | 0.06 | Why? |
| Family Relations | 1 | 2004 | 288 | 0.06 | Why? |
| Influenza Vaccines | 1 | 2017 | 2941 | 0.05 | Why? |
| Clinical Trials as Topic | 2 | 2018 | 7330 | 0.05 | Why? |
| Nasopharynx | 1 | 2020 | 10224 | 0.05 | Why? |
| Hemoglobins | 1 | 2007 | 958 | 0.05 | Why? |
| Heart Failure | 3 | 2017 | 6638 | 0.05 | Why? |
| Pulmonary Embolism | 1 | 2020 | 4775 | 0.05 | Why? |
| Residence Characteristics | 2 | 2018 | 1927 | 0.05 | Why? |
| Sweden | 2 | 2018 | 1969 | 0.05 | Why? |
| Prednisone | 1 | 2005 | 652 | 0.05 | Why? |
| Patient Admission | 1 | 1997 | 5250 | 0.05 | Why? |
| Cerebral Infarction | 1 | 2003 | 245 | 0.05 | Why? |
| Health Promotion | 3 | 2018 | 2020 | 0.05 | Why? |
| Risk Assessment | 2 | 2020 | 25439 | 0.05 | Why? |
| Nervous System Diseases | 1 | 2018 | 4092 | 0.05 | Why? |
| Neuromuscular Junction | 1 | 2018 | 18 | 0.05 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2017 | 5277 | 0.05 | Why? |
| Presbycusis | 1 | 2017 | 4 | 0.05 | Why? |
| Lysosomal-Associated Membrane Protein 2 | 1 | 2017 | 3 | 0.04 | Why? |
| Telomere Homeostasis | 1 | 2018 | 52 | 0.04 | Why? |
| Femur Neck | 1 | 2017 | 29 | 0.04 | Why? |
| Biological Transport | 1 | 2019 | 290 | 0.04 | Why? |
| Myography | 1 | 2017 | 6 | 0.04 | Why? |
| Forkhead Box Protein O3 | 1 | 2017 | 30 | 0.04 | Why? |
| Databases, Factual | 3 | 2018 | 6248 | 0.04 | Why? |
| Compulsive Behavior | 1 | 2018 | 53 | 0.04 | Why? |
| Protons | 1 | 2017 | 64 | 0.04 | Why? |
| Muscle Proteins | 1 | 2017 | 64 | 0.04 | Why? |
| Cost-Benefit Analysis | 2 | 2018 | 2259 | 0.04 | Why? |
| Survival Rate | 3 | 2015 | 9206 | 0.04 | Why? |
| Hearing Tests | 1 | 2017 | 76 | 0.04 | Why? |
| Health Policy | 1 | 2018 | 6242 | 0.04 | Why? |
| Survival Analysis | 2 | 2017 | 7592 | 0.04 | Why? |
| Creatine | 1 | 2017 | 66 | 0.04 | Why? |
| Thinness | 1 | 2017 | 99 | 0.04 | Why? |
| Phenotype | 2 | 2018 | 4037 | 0.04 | Why? |
| Hospital Mortality | 1 | 2021 | 22087 | 0.04 | Why? |
| Hospitalization | 3 | 2020 | 54280 | 0.04 | Why? |
| Hypotension, Orthostatic | 1 | 2017 | 55 | 0.04 | Why? |
| Oxidative Stress | 2 | 2018 | 2050 | 0.04 | Why? |
| Vaccination | 2 | 2019 | 19050 | 0.04 | Why? |
| Pharyngitis | 1 | 2020 | 687 | 0.04 | Why? |
| Microtubule-Associated Proteins | 1 | 2017 | 187 | 0.04 | Why? |
| Chest Pain | 1 | 2020 | 578 | 0.04 | Why? |
| Lumbar Vertebrae | 1 | 2017 | 196 | 0.04 | Why? |
| Lysosomes | 1 | 2019 | 416 | 0.04 | Why? |
| Off-Label Use | 1 | 2020 | 553 | 0.04 | Why? |
| Alarmins | 1 | 2017 | 180 | 0.04 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.04 | Why? |
| Adult | 11 | 2021 | 244371 | 0.04 | Why? |
| Time Factors | 5 | 2018 | 31397 | 0.04 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.04 | Why? |
| Life Style | 2 | 2018 | 2708 | 0.04 | Why? |
| Symptom Assessment | 2 | 2020 | 4967 | 0.04 | Why? |
| Geriatrics | 1 | 2005 | 947 | 0.04 | Why? |
| Nutrition Assessment | 1 | 2019 | 527 | 0.04 | Why? |
| Mental Disorders | 1 | 2018 | 6742 | 0.04 | Why? |
| Czech Republic | 1 | 2015 | 307 | 0.03 | Why? |
| Muscle Weakness | 1 | 2018 | 406 | 0.03 | Why? |
| Potassium | 1 | 2017 | 325 | 0.03 | Why? |
| Case-Control Studies | 3 | 2018 | 17671 | 0.03 | Why? |
| European Union | 1 | 2018 | 565 | 0.03 | Why? |
| Disease Progression | 2 | 2020 | 13580 | 0.03 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.03 | Why? |
| Rhinitis | 1 | 2020 | 626 | 0.03 | Why? |
| Finland | 1 | 2015 | 671 | 0.03 | Why? |
| Physical Endurance | 1 | 2014 | 107 | 0.03 | Why? |
| Depression | 1 | 2017 | 14116 | 0.03 | Why? |
| Probability | 1 | 2017 | 923 | 0.03 | Why? |
| Randomized Controlled Trials as Topic | 3 | 2017 | 10649 | 0.03 | Why? |
| Multivariate Analysis | 2 | 2018 | 5440 | 0.03 | Why? |
| Patient Care Planning | 1 | 1997 | 582 | 0.03 | Why? |
| Neuropsychological Tests | 1 | 2017 | 954 | 0.03 | Why? |
| Fibrinolytic Agents | 1 | 2003 | 1702 | 0.03 | Why? |
| Consumer Behavior | 1 | 2018 | 544 | 0.03 | Why? |
| Morbidity | 1 | 2018 | 1426 | 0.03 | Why? |
| Overweight | 1 | 2017 | 916 | 0.03 | Why? |
| Sex Distribution | 1 | 2018 | 2083 | 0.03 | Why? |
| Resistance Training | 1 | 2014 | 273 | 0.03 | Why? |
| Research Design | 2 | 2018 | 5830 | 0.03 | Why? |
| Prospective Studies | 4 | 2019 | 43301 | 0.03 | Why? |
| Advisory Committees | 1 | 2018 | 1418 | 0.03 | Why? |
| Young Adult | 5 | 2019 | 93724 | 0.03 | Why? |
| Observational Studies as Topic | 1 | 2018 | 1887 | 0.03 | Why? |
| Regression Analysis | 1 | 2017 | 2484 | 0.03 | Why? |
| Interpersonal Relations | 1 | 2017 | 926 | 0.02 | Why? |
| Models, Organizational | 1 | 2015 | 908 | 0.02 | Why? |
| Neoplasms | 1 | 2018 | 17251 | 0.02 | Why? |
| Sexual Behavior | 1 | 2018 | 1322 | 0.02 | Why? |
| Age Distribution | 1 | 2018 | 3567 | 0.02 | Why? |
| Animals | 4 | 2019 | 78931 | 0.02 | Why? |
| Severity of Illness Index | 4 | 2021 | 48226 | 0.02 | Why? |
| Denmark | 1 | 2015 | 2654 | 0.02 | Why? |
| Congresses as Topic | 1 | 2018 | 1347 | 0.02 | Why? |
| Adolescent | 4 | 2019 | 86841 | 0.02 | Why? |
| Early Diagnosis | 1 | 2016 | 2443 | 0.02 | Why? |
| Myocardial Ischemia | 1 | 2014 | 781 | 0.02 | Why? |
| Retrospective Studies | 6 | 2020 | 105322 | 0.02 | Why? |
| Surveys and Questionnaires | 4 | 2018 | 43792 | 0.02 | Why? |
| Netherlands | 1 | 2015 | 3533 | 0.02 | Why? |
| Psychomotor Performance | 1 | 2006 | 110 | 0.02 | Why? |
| Socioeconomic Factors | 1 | 2004 | 8495 | 0.02 | Why? |
| Pandemics | 7 | 2021 | 389249 | 0.02 | Why? |
| Anti-Inflammatory Agents | 1 | 2005 | 6153 | 0.02 | Why? |
| Alcohol Drinking | 1 | 2017 | 1663 | 0.02 | Why? |
| Benzodiazepines | 1 | 2006 | 163 | 0.02 | Why? |
| Odds Ratio | 1 | 2017 | 5861 | 0.02 | Why? |
| ROC Curve | 1 | 2017 | 6024 | 0.02 | Why? |
| Risk | 1 | 2017 | 5288 | 0.02 | Why? |
| Diet | 1 | 2017 | 2052 | 0.02 | Why? |
| Japan | 1 | 1997 | 6653 | 0.02 | Why? |
| Smoking | 1 | 2017 | 3358 | 0.02 | Why? |
| Curriculum | 1 | 1997 | 3083 | 0.02 | Why? |
| Decision Making | 1 | 1997 | 3132 | 0.02 | Why? |
| Length of Stay | 1 | 2021 | 11042 | 0.02 | Why? |
| Clinical Competence | 1 | 1997 | 3263 | 0.01 | Why? |
| Predictive Value of Tests | 1 | 2017 | 9537 | 0.01 | Why? |
| Brazil | 1 | 2019 | 12582 | 0.01 | Why? |
| Models, Biological | 1 | 2019 | 4907 | 0.01 | Why? |
| Bronchodilator Agents | 1 | 2006 | 444 | 0.01 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2020 | 11367 | 0.01 | Why? |
| Drug-Related Side Effects and Adverse Reactions | 1 | 2010 | 1261 | 0.01 | Why? |
| Signal Transduction | 1 | 2017 | 7207 | 0.01 | Why? |
| Germany | 1 | 2015 | 9196 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 13720 | 0.01 | Why? |
| Magnetic Resonance Imaging | 1 | 2017 | 6551 | 0.01 | Why? |
| United States | 2 | 1997 | 46150 | 0.01 | Why? |
| Sex Factors | 1 | 2017 | 11014 | 0.01 | Why? |
| Adrenal Cortex Hormones | 1 | 2017 | 6537 | 0.01 | Why? |
| Viral Load | 1 | 2020 | 15850 | 0.01 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.01 | Why? |
| Primary Health Care | 1 | 2017 | 4839 | 0.01 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 9335 | 0.01 | Why? |
| Secondary Prevention | 1 | 2003 | 762 | 0.01 | Why? |
| Cytokines | 1 | 2018 | 15010 | 0.01 | Why? |
| Hypertension | 1 | 2017 | 8895 | 0.01 | Why? |
| Prognosis | 1 | 2018 | 32490 | 0.01 | Why? |
| Global Health | 1 | 2018 | 13911 | 0.01 | Why? |
| Child, Preschool | 1 | 2018 | 36283 | 0.01 | Why? |
| Quarantine | 1 | 2020 | 18418 | 0.01 | Why? |
| Critical Pathways | 1 | 2003 | 1587 | 0.01 | Why? |
| RNA, Viral | 1 | 2020 | 32276 | 0.01 | Why? |
| Diabetes Mellitus | 1 | 2014 | 8207 | 0.01 | Why? |
| Delivery of Health Care | 1 | 2018 | 15909 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2017 | 25144 | 0.01 | Why? |
| Child | 1 | 2018 | 70012 | 0.01 | Why? |
| Reproducibility of Results | 1 | 2005 | 11304 | 0.01 | Why? |
| Attitude of Health Personnel | 1 | 2003 | 4741 | 0.00 | Why? |